Novo Nordisk (NVO) free cash flow

Free cash flow · fiscal 2025
DKK 28.99B

Novo Nordisk (NVO) generated free cash flow of DKK 28.99B in fiscal 2025 (the year ended December 31, 2025). That is 58.4% lower than the DKK 69.66B of fiscal 2024. Figures as of 18 Nov 2026, 12:22 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
DKK 28.99B
Change on fiscal 2024
−58.4%
Highest on record
DKK 70.01Bfiscal 2023
Lowest on record
DKK 28.99Bfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in DKK. Figures, not advice.

Novo Nordisk free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was DKK 70.01B in fiscal 2023 and the lowest DKK 28.99B in fiscal 2025.

History · 4 fiscal years

Free cash flow by fiscal year

Novo Nordisk free cash flow, year by year

Novo Nordisk (NVO) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025DKK 28.99B 58.4% down
2024DKK 69.66B 0.5% down
2023DKK 70.01B 9.2% up
2022DKK 64.13B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Novo Nordisk and comparable companies
CompanyFree cash flowFiscal year
Gilead Sciences GILD$9.46B2025
Abbott Laboratories ABT$7.40B2025
Novo Nordisk NVODKK 28.99B2025
Pfizer PFE$9.08B2025
Danaher DHR$5.26B2025
Intuitive Surgical ISRG$2.49B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVO

Novo Nordisk, figure by figure

Novo Nordisk (NVO) overview: price, valuation and scorecardAll health care companies by market value

Novo Nordisk free cash flow: questions and answers

What is Novo Nordisk's free cash flow?

Novo Nordisk (NVO) generated free cash flow of DKK 28.99B in fiscal 2025 (the year ended December 31, 2025). That is 58.4% lower than the DKK 69.66B of fiscal 2024.

What are the highest and lowest free cash flow figures on record for Novo Nordisk?

Across the 4 fiscal years on record (2022–2025), the highest was DKK 70.01B in fiscal 2023 and the lowest DKK 28.99B in fiscal 2025.

How is Novo Nordisk's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Novo Nordisk it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novo Nordisk (NVO) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/NVO/free-cash-flow

Underlying data: Yahoo Finance.